These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26582241)

  • 1. Progress in the development of protein biomarkers of oesophageal and gastric cancers.
    Coghlin C; Murray GI
    Proteomics Clin Appl; 2016 Apr; 10(4):532-45. PubMed ID: 26582241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
    Davidson M; Chau I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of response to therapy in oesophago-gastric cancer.
    Fareed KR; Kaye P; Soomro IN; Ilyas M; Martin S; Parsons SL; Madhusudan S
    Gut; 2009 Jan; 58(1):127-43. PubMed ID: 19091831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic and metabolic prediction of response to therapy in gastric cancer.
    Aichler M; Luber B; Lordick F; Walch A
    World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant therapy for oesophagogastric cancer.
    Lordick F; Stein HJ; Peschel C; Siewert JR
    Br J Surg; 2004 May; 91(5):540-51. PubMed ID: 15122603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
    Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
    Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
    De Mello RA; Castelo-Branco L; Castelo-Branco P; Pozza DH; Vermeulen L; Palacio S; Salzberg M; Lockhart AC
    Am Soc Clin Oncol Educ Book; 2018 May; 38():249-261. PubMed ID: 30231398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
    Höfler H; Langer R; Ott K; Keller G
    Recent Results Cancer Res; 2007; 176():33-6. PubMed ID: 17607914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
    Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
    Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Therapeutic Biomarkers in Gastro-Esophageal Junction and Gastric Cancer Should a Pathologist Know About?
    Kumarasinghe MP; Houghton D; Allanson BM; Price TJ
    Surg Pathol Clin; 2023 Dec; 16(4):659-672. PubMed ID: 37863558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncoproteomics: Trials and tribulations.
    Zhou L; Li Q; Wang J; Huang C; Nice EC
    Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal cancer: facts, myths and surgical folk lore.
    Park KG
    J R Coll Surg Edinb; 2002 Dec; 47(6):716-30. PubMed ID: 12510964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating molecular biomarkers into clinical practice for gastric cancer.
    Nakamura S; Kanda M; Kodera Y
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):757-771. PubMed ID: 31437076
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomics of Esophageal Cancer and Biomarkers for Early Detection.
    Pusung M; Zeki S; Fitzgerald R
    Adv Exp Med Biol; 2016; 908():237-63. PubMed ID: 27573775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Alexander BM; Wang XZ; Niemierko A; Weaver DT; Mak RH; Roof KS; Fidias P; Wain J; Choi NC
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):164-71. PubMed ID: 22000749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
    Mu YP; Sun WJ; Lu CW; Su XL
    Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.
    Maher SG; McDowell DT; Collins BC; Muldoon C; Gallagher WM; Reynolds JV
    Ann Surg; 2011 Nov; 254(5):809-16; discussion 816-7. PubMed ID: 22005152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
    Wang S; Yuan L
    Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
    Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
    Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.